Abstract
HIV-infected persons entering the criminal justice system (CJS) often experience suboptimal healthcare system engagement and social instability, including homelessness. We evaluated surveys from a multisite study of 743 HIV-infected jail detainees prescribed or eligible for antiretroviral therapy (ART) to understand correlates of healthcare engagement prior to incarceration, focusing on differences by housing status. Dependent variables of healthcare engagement were: 1) having an HIV provider, 2) taking ART, and 3) being adherent (>95% of prescribed doses) to ART during the week before incarceration. Homeless subjects, compared to their housed counterparts, were significantly less likely to be engaged in healthcare using any measure. Despite Ryan White funding availability, insurance coverage remains insufficient among those entering jails, and having health insurance was the most significant factor correlated with having an HIV provider and taking ART. Individuals interfacing with the CJS, especially those unstably housed, need innovative interventions to facilitate healthcare access and retention.
Keywords: HIV, AIDS, Homelessness, jail, incarceration, substance abuse, alcohol, insurance, Adherence, healthcare access
Introduction
The United States has the highest incarceration rate of any industrialized country with an average daily census of over 760,000 jail detainees and more than 13 million adult admissions to jails annually (1, 2). The overwhelming majority of jail detainees return to the community, and 50% of jail detainees are released within 48 hours (3). After incarceration, the transition to the community is a vulnerable period, as former inmates often have difficulty obtaining housing, finding employment, and accessing health care (4–6). Little is known, however, about the vulnerability of individuals in the period just before incarceration.
Moreover, the post-release transitional period is better described for HIV-infected prisoners than for jail detainees. Compared to prisons, jails generally house inmates who are either unsentenced or sentenced to shorter terms (less than 12 to 24 months). Among HIV-infected former prisoners, the benefits of antiretroviral therapy (ART) seen during imprisonment (increased CD4 cell count and high rates of viral suppression) are frequently lost after release to the community (7, 8). The reasons for these poor outcomes are complex and not fully understood (9). For example, despite medication assistance programs that guarantee free antiretroviral medications after release, only 5% of Texas prisoners obtained their HIV medications within 10 days of release – when their discharge supply of medications would have been exhausted (10). Additionally, relapse to drug or alcohol use immediately post-release, may contribute to poor outcomes. HIV-infected prisoners meeting criteria for opioid dependence who initiated buprenorphine at the time of prison-release, maintained their viral suppression during the vulnerable post-release period, confirming that effective substance abuse treatment improves previously described post-release outcomes (11). Reasons for disrupted prescription refills and poor adherence to HIV care following prison release are therefore multifactorial and may include relapse to substance use, untreated mental health issues, social instability including homelessness, and lack of medical insurance (4–6, 12–15).
Approximately 23–68% of homeless individuals have a history of incarceration (16, 17). Homelessness increases incarceration risk through common risk behaviors, such as substance abuse and transactional sex, and the criminalization of homelessness (5, 16–19). Incarceration also increases risk of homelessness through loss of employment, loss of housing, and disruption of social support or medical or social benefits (5, 17). Among non-incarcerated people living with HIV/AIDS (PLWHA), homelessness and unstable housing have been associated with suboptimal HIV outcomes including poor adherence to HIV medications, fewer primary care visits, and increased risk of death (4, 20, 21). Therefore, homelessness and incarceration may synergistically exacerbate the risk for poor HIV treatment outcomes.
Approximately one in six PLWHA pass through the criminal justice system (CJS) annually (22), suggesting that the CJS is an opportune setting to identify new HIV diagnoses, initiate HIV treatment, and retain persons in care (23). Although some inmates are only adherent to medications while incarcerated, even intermittent ART has been demonstrated to provide immunological and virologic benefit compared to those who never received ART (24). Thus, jail settings may represent a unique point for public health interventions among these HIV-infected individuals.
Linking HIV-infected inmates to HIV primary care services upon release from correctional settings is essential to improving health outcomes among the recently incarcerated. The transition to the community is a highly vulnerable time for former inmates, and the additional complication of social instability and homelessness may exacerbate their risk of poor HIV outcomes. Individuals who experience homelessness prior to incarceration may experience additional challenges to maintaining adherence to medications or having a regular HIV provider. In recognition that the time of incarceration provides a unique window to retrospectively assess the relationship of PLWHA to healthcare access and utilization, the objectives of these analyses were to compare homeless and non-homeless individuals prior to incarceration and (1) describe their differences in demographic profile, substance use, and mental health history; (2) examine factors associated with having an HIV treatment provider; and (3) understand the factors associated with HIV medication adherence. A more in-depth understanding of the interaction between homelessness and healthcare engagement, especially since homelessness, substance abuse, and mental illness are associated with reincarceration, would inform individual and public health post-release interventions from jails.
Theoretical/Conceptual Framework of Current Study
The Behavioral Model for Vulnerable Populations guided this analysis (25, 26). This model of healthcare utilization asserts that there are predisposing, enabling, and need factors that impact the utilization of health services. Figure 1 presents this model, adapted from Gelberg, et al, with the factors impacting linkage to care that are most relevant to homelessness and incarceration (26). Predisposing factors are demographic and social structure characteristics intrinsic to the individual that impact healthcare utilization. In this population of jail detainees, we included current housing status and history of mental and substance use disorders (SUDs) as additional predisposing factors. Enabling resources are personal and community resources that facilitate linkage to care. In this vulnerable population, we regard food security, anticipated housing situation, health insurance, stable living situation, and history of drug or psychiatric treatment as enabling resources that positively affect linkage to care. Need factors are determined by an individual’s perceived health needs or priorities, severity of disease and their actual health status. Need factors typically take into account medical co-morbidities and severity of illness, and in our study they included having active medical problems, psychiatric, or substance use disorders.
Figure 1.
Conceptual model of health behaviors among the HIV-infected persons during the pre-incarceration period
Abbreviations: ART Antiretroviral therapy
In this manuscript, we provide a snapshot of the degree to which HIV-infected persons are engaged in HIV care as they migrate into jail, primarily focusing on the differences between previously homeless and non-homeless individuals. The Health Resources and Services Administration (HRSA) describes a spectrum of engagement in HIV care ranging from those who are unaware of their infection and not receiving any HIV care to those that are fully engaged in HIV care (27). Gardner, et al further defined levels of engagement in care as those who are retained in HIV care, those who need and receive ART, and finally those who are adherent and achieve complete viral suppression (28). Compatible with this spectrum of engagement, we analyzed the following step-wise progression of engagement in care: (1) having an HIV provider, (2) taking prescribed ART in the seven days prior to incarceration, (3) and among those who report taking ART, the level of adherence to ART (figure 1). We used the period immediately prior to incarceration as a window into previous healthcare use, recognizing that the period of incarceration is a disruptive time in the lives of PLWHA.
Methods
We performed a cross-sectional analysis from a mid-term review of data from the baseline interviews of HIV-infected jail detainees enrolled in the Enhancing Linkages to HIV Primary Care and Services in Jail Settings Initiative.
Study setting
Enhancing Linkages to HIV Primary Care and Services in Jail Settings Initiative is a HRSA-funded Special Projects of National Significance (SPNS). This initiative funds ten sites in nine states (CT, GA, IL, MA, NY, OH, PA, SC, RI) to design, implement, and evaluate new methods for linking PLWHA who are recently released from jails to primary HIV medical care and ancillary services (29, 30). Although eligibility criteria differed slightly between sites, all sites recruited HIV-infected jail detainees aged ≥18 years. New York City excluded subjects with serious mental illness and Chicago included only women. Data were retrieved for the first 871 subjects enrolled from September 2007 to October 8, 2010. Since we were interested in engagement in HIV care prior to incarceration, we excluded individuals newly diagnosed with HIV during the current incarceration and those who did not meet criteria for ART (no history of antiretroviral therapy and CD4 count greater than 350 cells/mL) (n=126) (31). Of the remaining 745 individuals, only two did not have data regarding having an HIV provider and they were excluded from the analysis leaving a total study sample of 743 individuals, of which 312 (42%) were homeless and 431 (58%) were non-homeless persons.
The multisite study was approved by Rollins School of Public Health of Emory University and Abt Associates Institutional Review Board, and was approved and overseen by the individual institutional IRBs as appropriate to the level of involvement at each site. A certificate of confidentiality was also obtained for the study.
Study Instruments
Dependent Variables of Interest
To assess the degree to which subjects were engaged in care just prior to incarceration, we chose three dependent variables based on HRSA guidance: (1) having an HIV provider at the time of incarceration, (2) having taken any ART in the seven days prior to incarceration, and (3) among those who reported taking ART prior to incarceration, having >95% self-reported adherence to the medications in the past seven days (32, 33).
Independent Variables of Interest
In accordance with the Behavioral Model for Healthcare Utilization, we analyzed the predisposing factors, enabling resources and need factors depicted in figure 1. The primary covariate of interest was housing status, which was classified as homeless versus non-homeless. Homelessness was defined by self-report, and individuals were also considered homeless if they reported sleeping in a shelter, streets or parks, empty building, bus station, or some other public place in the 30 days before incarceration. Demographic variables included gender, age, race/ethnicity, education level, marital status, and employment status. History of substance use and mental disorder were by self-report. Specifically, participants were asked about recent (30 days before incarceration) and lifetime substance use for each of the following substances: alcohol, heroin or other non-prescribed opioids, methadone, buprenorphine, barbiturates, other non-prescribed sedatives, cocaine, benzodiazepines, amphetamines, cannabis, hallucinogens, inhalants, and multiple drug use (more than one substance on any given day). Health beliefs regarding healthcare was not available for subjects.
Enabling resources of interest included health insurance status at time of incarceration, food security, anticipated housing status after release, and history of psychiatric or drug treatment, which were all determined by self-report. Food insecurity was defined as going without food for two or more days in the 30 days prior to incarceration. Information on social support was not available. Study site was also included as available resources differed by location.
Need factors included active medical problems and psychiatric or substance use severity, which were all determined by self-report. Individuals were considered as having “active medical problems” if they experienced a medical problem other than HIV in the 30 days before incarceration. Substance use severity was determined by the Addiction Severity Index (ASI) fifth edition (34, 35). ASI drug and alcohol composite scores (CS) were calculated with each ranging from zero to one with one indicating more severe disease (34–36). Severity of mental illness was ascertained from the ASI psychiatric component CS and was analyzed as both a linear and a dichotomous variable with cutoff at 0.22 since this has threshold has demonstrated 90% sensitivity and 71% specificity in identifying mental illness (34, 35, 37).
Statistical Analysis
All analyses were stratified by housing status to ensure assessing the relationship between any cofactor (e.g. substance abuse) with homelessness. Comparison of baseline characteristics was performed using Chi-square test for dichotomous variables and Student’s t-test for continuous variables, specifying significance level of α=0.05. For analysis of all three dependent variables, we performed univariate analysis using logistic regression examining all predisposing factors, enabling resources, and need factors as described above. Covariates with a p<0.10 on univariate analysis were included in the multivariate logistic regression. Variance inflation factor analysis did not reveal any significant collinear variables. Effect modification was assessed for all the selected factors. Model comparison was done by likelihood ratio testing, using Akaike’s information criterion (AIC) to assess model fit. All statistical analyses were performed using STATA 10.0 (College Station, TX).
Results
Table 1 compares the demographic, substance use, and medical and psychiatric profile between homeless (n=312) and non-homeless (n=431) HIV-infected jail detainees. The predominant profile for an enrolled jail detainee in this analysis was an unmarried, African-American man in his 40’s who had never completed high school, was not regularly employed, had used illegal drugs in the past (with cocaine being the most common), and who had an HIV provider and was taking ART in the week prior to incarceration, but was less than 95% adherent with ART.
Table 1.
Demographic and risk behavior profiles of HIV infected jail detainees, stratified by pre-incarceration housing status
Not homeless N=431 (%) | Homeless N=312 (%) | p-value | |
---|---|---|---|
Demographics
| |||
Male | 298 (69.1%) | 194 (62.4%) | 0.07 |
Transgender | 6 (1.4%) | 7 (2.3%) | 0.14 |
Mean age, years (SD) | 44.7 (8.6) | 43.3 (8.2) | 0.02 |
Never completed high school | 213 (49.6%) | 165 (53.2%) | 0.35 |
Not in a relationship | 272 (63.4%) | 233 (74.7%) | 0.001 |
Non-Hispanic White (referent) | 62 (14.4%) | 45 (14.4%) | |
Non-Hispanic Black | 259 (60.1%) | 186 (59.6%) | 0.95 |
Hispanic | 110 (25.5%) | 81 (26.0%) | 0.95 |
Sexual orientation: Heterosexual | 340 (79.1%) | 242 (77.8%) | 0.73 |
Hunger: Went for ≥2 days without food | 92 (21.5%) | 188 (60.7%) | <0.001 |
Anticipated housing on release: homeless/unknown | 105 (24.5%) | 132 (42.7%) | <0.001 |
Age <18 years at first arrest | 172(42.4%) | 152 (50.0%) | 0.05 |
Regular employment (full or part time) over the last 3 years | 75 (17.6%) | 37 (12.0%) | 0.04 |
| |||
Substance Use
| |||
Drug use, ever: | |||
Heroin/opioids | 187 (43.4%) | 141 (45.2%) | 0.63 |
Benzodiazepines | 39 (9.3%) | 45 (14.5%) | 0.03 |
Cocaine | 338 (79.3%) | 263 (84.8%) | 0.06 |
Any illegal drug | 417 (96.8%) | 304 (97.4%) | 0.59 |
Multiple drugs | 249 (61.6%) | 214 (72.3) | 0.003 |
Drug use, recent (30 days prior to incarceration): | |||
Heroin/opiate | 118 (27.4%) | 95 (30.5%) | 0.36 |
Benzodiazepine | 19 (4.5%) | 38 (12.3%) | <0.001 |
Cocaine | 195 (46.0%) | 197 (63.8%) | <0.001 |
Any illegal drug | 324 (75.2%) | 259 (83.0%) | 0.01 |
Multiple drugs | 167 (41.1%) | 168 (57.0%) | <0.001 |
Alcohol use, recent (30 days prior to incarceration) | 179 (42.0%) | 161 (51.9%) | 0.009 |
Ever experienced Delirium tremens | 42 (9.9%) | 45 (14.6%) | 0.05 |
Ever been in Alcohol treatment | 108 (25.5%) | 90 (30.2%) | 0.16 |
Ever been in Drug treatment | 301(71.0%) | 227 (73.7%) | 0.39 |
Addiction Severity, mean (SD) ASI score-Drugs | 0.19 (0.15) | 0.26 (0.16) | <0.001 |
Addiction Severity, mean (SD) ASI score-Alcohol | 0.20 (0.21) | 0.26 (0.24) | <0.001 |
| |||
Medical and Psychiatric Co-morbidities
| |||
Tuberculosis | 10 (2.3%) | 9 (2.8%) | 0.63 |
Hepatitis B | 32 (7.4%) | 29 (9.3%) | 0.35 |
Hepatitis C | 148 (34.3%) | 131 (42.0%) | 0.03 |
Active other medical problems | 154 (36.4%) | 148 (48.7%) | 0.001 |
Had insurance at time of incarceration | 352 (81.9%) | 210 (67.3%) | <0.001 |
Type of Insurance at time of incarceration | |||
Medicaid | 279 (64.7%) | 169 (54.2%) | 0.004 |
AIDS Drug Assistance Program | 48 (11.1%) | 33 (10.6%) | 0.81 |
Medicare | 23 (5.3%) | 20 (6.4%) | 0.54 |
Private/Other/Don’t know | 79 (18.3%) | 39 (12.5%) | 0.032 |
Inpatient treatment for psychiatric problems | 125 (29.3%) | 132 (43.3%) | <0.001 |
Outpatient treatment for psychiatric problems | 107 (24.8%) | 108 (34.6%) | 0.004 |
Prescribed psychiatric medications: 30 days prior to jail | 101 (23.4%) | 90 (29.2%) | 0.09 |
Experienced severe depression/anxiety: 30 days prior to jail | 225 (52.1%) | 202 (64.7%) | 0.001 |
Addiction Severity, mean (SD) ASI score-Psychiatric | 0.15 (0.20) | 0.20 (0.31) | 0.006 |
Severe psychiatric illness (ASI>0.22) | 123 (28.5%) | 122 (39.1%) | 0.003 |
| |||
Engagement in HIV Care
| |||
Had an HIV provider 30 days prior to incarceration | 355 (82.4%) | 202 (64.7%) | <0.001 |
Took HIV medication in 7 days prior to incarceration | 238 (62.3%) | 123 (45.4%) | <0.001 |
High antiretroviral adherence (≥95%) in 7 days prior to jail | N=236 147 (62.3%) | N=119 61(51.3%) | 0.05 |
Abbreviations: SD= standard deviation; ASI=Addiction Severity Index
Stratification by housing status, however, identified some notable differences. Homeless individuals were more likely to report recent substance use (especially with alcohol, benzodiazepine, cocaine, any drug, or multiple concurrent drug use) and have co-morbid and more severe psychiatric illnesses than non-homeless individuals. Homeless individuals were also less likely to report having medical insurance, having an HIV provider, taking ART or being adherent to it.
Table 2 examines the independent correlates of having an HIV provider prior to incarceration among both the homeless and non-homeless jail detainees. Having health insurance was the most significant factor (AOR=4.5, 95% CI 2.2–9.2 among the non-homeless; AOR 4.7, 95% CI 2.5–9.0 among the homeless) associated with having an HIV provider prior to incarceration
Table 2.
Factors associated with having an HIV provider among homeless and non-homeless jail detainees *
Non-homeless, n=431 | Homeless, n=312 | |||
---|---|---|---|---|
| ||||
Unadjusted OR (95% CI) | Adjusted OR (95% CI) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | |
Gender | ||||
Male | Referent | Referent | Referent | Referent |
Female | 0.66 (0.39, 1.12) | 1.14(0.52, 2.49) | 1.03 (0.63, 1.67) | 0.89 (0.47, 1.66) |
Age (years), continuous | 1.04 (1.01, 1.07) | 1.02 (0.99, 1.06) | 1.01 (0.98, 1.04) | 1.02 (0.98, 1.06) |
Anticipated Housing Upon Release | ||||
Has place to live | Referent | -- | Referent | Referent |
Homeless/unknown | 0.69 (0.40, 1.20) | 0.69 (0.43, 1.10) | 0.44 (0.25, 0.78) | |
Heroin/opiate use: ever | ||||
No | Referent | Referent | Referent | -- |
Yes | 2.30 (1.33, 3.96) | 1.71 (0.85, 3.44) | 1.10 (0.69, 1.76) | |
Multiple drug use: more than one illicit substance, past 30 days | ||||
No | Referent | Referent | Referent | Referent |
Yes | 0.66 (0.40, 1.09) | 0.53 (0.26, 1.05) | 0.60 (0.37, 0.99) | 0.58 (0.32, 1.06) |
Alcohol use: any use, past 30 days | ||||
No | Referent | Referent | Referent | Referent |
Yes | 1.47 (0.88, 2.47) | 2.31 (1.15, 4.64) | 0.79 (0.49, 1.26) | 1.99 (0.93, 4.24) |
ASI-Alcohol Composite Score | 2.42 (0.64, 9.15) | 2.37 (0.33, 17.04) | 0.40 (0.16, 1.02) | 0.20 (0.04, 0.90) |
Health Insurance Prior to Jail | ||||
No | Referent | Referent | Referent | Referent |
Yes | 6.19 (3.57, 10.76) | 4.45 (2.15, 9.21) | 4.89 (2.94, 8.13) | 4.69 (2.46, 8.95) |
Outpatient Psychiatric Treatment | ||||
No | Referent | Referent | Referent | Referent |
Yes | 2.66 (1.32, 5.38) | 2.45 (1.08, 5.54) | 1.79, (1.08, 2.96) | 2.54 (1.29, 4.99) |
also controlled for site
univariate analysis also performed for education level, marital status, race/ethnicity, food insecurity, recent drug use (cocaine, benzodiazepines, marijuana, amphetamines, opiates, multiple drugs, or any drug use), ASI-drugs, history of drug or alcohol treatment, history of psychiatric hospitalization, ASI-psychiatric both dichotomous and continuous, outpatient psychiatric treatment, psychiatric medication use, hepatitis C co-infection, active medical problems, but none of these were significant either on univariate analysis or in the final model when incorporated if p<0.10 in the univariate analysis.
Abbreviations: ASI=Addiction Severity Index
Alcohol use influenced the likelihood of having a HIV provider differently among homeless and non-homeless jail detainees. For non-homeless detainees, any alcohol use during the 30 days prior to incarceration was associated with increased likelihood (AOR=2.3, 95% CI 1.2–4.6) of having an HIV provider, whereas for homeless detainees, increasing severity of alcohol use on the ASI was associated with decreased likelihood (AOR=0.20; 95% CI 0.04–0.90) of having an HIV provider. Among the homeless, expected homelessness or uncertainty about housing upon release was also associated with decreased likelihood of having an HIV provider (AOR=0.44; 95% CI 0.25–0.78).
In Table 3, homeless (n=271) and non-homeless (n=382) subjects were stratified to examine factors associated with ART use among those who reported whether or not they were taking ART in the seven days prior to incarceration. For all jail detainees, irrespective of housing status, having health insurance was the most significant factor associated with taking ART.
Table 3.
Factors associated with taking antiretroviral therapy in the 7 days prior to incarceration
Non-homeless, n=382 | Homeless, n=271 | |||
---|---|---|---|---|
| ||||
Unadjusted OR (95% CI) | Adjusted OR (95% CI) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | |
Gender | ||||
Male | Referent | Referent | Referent | Referent |
Female | 0.47 (0.30, 0.75) | 0.51 (0.29, 0.90) | 0.54 (0.32, 0.90) | 0.36 (0.17, 0.75) |
Age, continuous | 1.05 (1.02, 1.08) | 1.04 (1.01, 1.07) | 1.02 (0.99, 1.06) | 1.01 (0.97, 1.06) |
Completed high school or equivalent | ||||
Yes | Referent | -- | Referent | Referent |
No | 0.78 (0.52, 1.18) | 0.62 (0.38, 1.01) | 0.55 (0.29, 1.04) | |
Lived with a drug user: past 30 days | ||||
No | Referent | -- | Referent | Referent |
Yes | 1.06 (0.64, 1.76) | 0.67 (0.41, 1.09) | 0.75 (0.41, 1.40) | |
Food insecurity | ||||
Did not experience hunger | Referent | -- | Referent | Referent |
Experienced hunger | 0.67 (0.41, 1.12) | 0.52 (0.32, 0.85) | 0.49 (0.25, 0.95) | |
Health Insurance Prior to Jail | ||||
No | Referent | Referent | Referent | Referent |
Yes | 2.99 (1.68, 5.31) | 4.56 (2.16, 9.61) | 4.29 (2.38, 7.71) | 4.71 (2.21, 10.0) |
Active medical problems | ||||
No | Referent | -- | Referent | Referent |
Yes | 0.73 (0.48, 1.13) | 1.84 (1.13, 3.01) | 2.65 (1.39, 5.06) | |
Cocaine use: past 30 days | ||||
No | Referent | -- | Referent | Referent |
Yes | 0.47 (0.30, 0.71) | 0.30 (0.18, 0.50) | 0.33 (0.15, 0.75) | |
Any substance use: past 30 days | ||||
No | Referent | Referent | Referent | Referent |
Yes | 0.47 (0.28, 0.79) | 0.45 (0.22, 0.88) | 0.39 (0.20, 0.76) | 0.99 (0.36, 2.74) |
ASI-Drugs Composite Score | 0.13 (0.03, 0.54) | 0.50 (0.08, 3.21) | 0.10 (0.02, 0.51) | 2.01 (0.16, 25.6) |
ASI-Alcohol Composite Score | 0.37 (0.14, 0.96) | 0.59 (0.20, 1.76) | 0.61 (0.23, 1.66) | 0.85 (0.23, 3.15) |
also controlled for site
univariate analysis also performed for marital status, race/ethnicity, recent drug use (benzodiazepines, marijuana, amphetamines, opiates, multiple drug use), history of drug or alcohol treatment, recent alcohol use, history of psychiatric hospitalization, ASI-psychiatric both dichotomous and continuous, outpatient/inpatient psychiatric treatment, psychiatric medication use, hepatitis C co-infection, but none of these were significant either on univariate analysis or in the final model checking when incorporated if p<0.10 in the univariate analysis.
Abbreviations: ASI=Addiction Severity Index
Among those reporting not being homeless, any drug use in the 30 days before jail was associated with a decreased likelihood of taking ART. On univariate analysis, recent cocaine use was also associated with decreased likelihood of taking ART, but the association was no longer significant on multivariate analysis nor did it improve the final model validity (data not shown).
Correlates of taking ART among the homeless were different. Having an active non-HIV-related medical problem was associated with an increased likelihood of taking ART, recent cocaine use decreased this likelihood. Moreover, unlike that found among the non-homeless group, food insecurity was associated with a more than 50% decreased likelihood of taking ART. Having health insurance, however, modified the effect of food insecurity among the homeless; homeless individuals who experienced hunger but who also had health insurance had a 3.05 adjusted odds ratio (95% CI 1.24, 7.49) of taking their ART in the seven days prior to incarceration, compared to those who experienced hunger but had no health insurance (data not shown).
We examined factors associated with optimal adherence, defined as taking ≥95% of prescribed ART doses among the homeless (n=119) and non-homeless (n=236) who were on ART in the week prior to incarceration (Table 4). Sixty-two percent (n=147) of the non-homeless reported optimal adherence compared to 51% (n=61) of homeless individuals (p=0.05). Among the non-homeless, optimal adherence was associated with being single and not having active medical problems. There was a trend towards decreased adherence with alcohol use, cocaine use, and drug severity, although these were not statistically significant after adjustment for other covariates.
Table 4.
Factors associated with optimal medication adherence (>95%) among non-homeless and homeless jail detainees who were taking medications 7 days prior to incarceration
Non-homeless (N=236) | Homeless (N=119) | |||
---|---|---|---|---|
| ||||
Unadjusted OR (95% CI) | Adjusted OR (95% CI) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | |
Gender | ||||
Male | Referent | Referent | Referent | Referent |
Female | 0.81 (0.43, 1.52) | 1.17 (0.56, 2.24) | 0.93 (0.41, 2.10) | 0.91 (0.38, 2.19) |
Age, continuous | 1.00 (0.97, 1.03) | 0.98 (0.95, 1.02) | 1.02 (0.97, 1.07) | 1.02 (0.97, 1.07) |
Race/Ethnicity | ||||
Non-Hispanic White | Referent | Referent | Referent | |
Non-Hispanic Black | 0.72 (0.34, 1.56) | -- | 4.18 (1.25, 14.0) | 5.12 (1.41, 18.5) |
Hispanic | 0.73 (0.31, 1.69) | -- | 5.38 (1.45, 20.0) | 5.03 (1.30, 19.5) |
Marital Status | ||||
Married/committed | Referent | Referent | Referent | |
Single/not in a relationship | 1.79 (1.04, 3.06) | 1.83 (1.04, 3.19) | 0.59 (0.26, 1.34) | -- |
Food insecurity | ||||
Did not experience hunger | Referent | Referent | Referent | |
Experienced hunger | 1.03 (0.52, 2.03) | -- | 0.44 (0.21, 0.91) | 0.41 (0.19, 0.89) |
Active medical problems | ||||
No | Referent | Referent | Referent | |
Yes | 0.47 (0.27, 0.83) | 0.55 (0.31, 0.97) | 0.51 (0.24, 1.06) | -- |
Had health Insurance | ||||
No | Referent | Referent | ||
Yes | 0.76 (0.30, 1.94) | -- | 2.01 (0.73, 5.53) | -- |
Any Cocaine use: past 30 days | ||||
No | Referent | Referent | Referent | |
Yes | 0.48 (0.28, 0.83) | 0.68 (0.35, 1.35) | 0.56 (0.27, 1.17) | -- |
Any opiate use: past 30 days | ||||
No | Referent | Referent | Referent | |
Yes | 0.92 (0.51, 1.67) | -- | 0.30 (0.10, 0.91) | 2.02 (0.78, 5.19) |
Any Alcohol use: past 30 days | ||||
No | Referent | Referent | Referent | |
Yes | 0.46 (0.27, 0.80) | 0.56 (0.31, 0.99) | 0.60 (0.29, 1.25) | -- |
ASI-Alcohol Composite | 0.56 (0.15, 2.12) | -- | 0.90 (0.40, 2.03) | -- |
ASI-Drug Composite | 0.15 (0.02, 0.98) | 0.34 (0.03, 3.34) | 2.86 (0.34, 23.9) | -- |
ASI-Psychiatric Composite | 0.53 (0.10, 2.90) | -- | 0.59 (0.19, 1.80) | -- |
Univariate analysis also performed for education level, anticipated housing status upon release, recent drug use (benzodiazepines, amphetamines, multiple drug use, and any drug use), history of drug or alcohol treatment, outpatient/inpatient psychiatric treatment, psychiatric medication use, report of recent severe depression/anxiety, and hepatitis C co-infection, but none of these were significant either on univariate analyses or in the final model checking when incorporated if p<0.10 in the univariate analysis.
Abbreviations: ASI=Addiction Severity Index
Among the homeless, non-Hispanic blacks and Hispanics were more likely to report ≥95% adherence to ART compared to non-Hispanic whites. Suboptimal adherence (<95%) was associated with experiencing food insecurity. None of the drug use or addiction severity variables were associated with medication adherence.
Discussion
In this multisite study of jail detainees with previously-diagnosed HIV, we confirmed that nearly half (42%) were homeless when they entered jail. The complicated interactions between homelessness and incarceration pose seemingly insurmountable challenges for engagement in HIV care. In this sample, homeless jail detainees were more likely to have a higher prevalence and increased severity of substance use, medical and psychiatric disorders than the non-homeless, suggesting the need for initiating or continuing treatment for both conditions during and after release from jail. Both psychiatric and substance use disorders are associated with decreased health care access and utilization, including adherence to antiretroviral therapy, among non-incarcerated populations (38). Substance use, specifically alcohol and cocaine use, significantly decreased likelihood of accessing HIV care (having an HIV provider and taking ART in the seven days prior to incarceration) among homeless individuals. Along every step of the continuum of engagement in HIV care (28), homeless individuals were less likely to be engaged in care when compared to non-homeless jail detainees, suggesting the need for interventions that incorporate special provisions to address homelessness in both community and jail-release interventions.
Guided by the Behavioral Model for Vulnerable populations (Figure 1), we focus our discussion primarily on the modifiable factors critical to jail detainees, with an independent assessment of the contribution of homelessness on HIV health outcomes. Importantly, for all jail detainees irrespective of their housing status, having health insurance prior to arrest was the most important factor associated with having an HIV provider and taking ART in the week before incarceration. Multiple factors may contribute to an inability to obtain health insurance. Private insurance is typically prohibitive to this patient population secondary to high costs and exclusion for HIV as a pre-existing condition. Employee-based insurance may be equally unreliable in this often-migratory population, as they cycle between communities and the criminal justice system. Acquiring public assistance, such as Medicaid, involves meeting strict poverty requirements (with limited eligibility for men) and qualification for Medicare disability requires a debilitating sickness, which does not include properly-managed HIV (39). Having acquired public assistance in the form of health insurance may, therefore, be an indication of illness severity in some settings where these entitlements are constrained. The Ryan White HIV/AIDS Treatment Modernization Act is the safety net and provider of last resort for PLHWA that theoretically allows all HIV-infected individuals to receive some modicum of medical care (40), but waiting lists, limited providers, flat to decreased funding, and lack of awareness of the program by both patients and non-HIV providers remain as significant barriers. Ryan White is not an insurance plan. Having public entitlements such as health insurance require that an individual is socially organized enough to comply with the complicated and strict application processes, which is challenging for a population with such a high prevalence of active substance use and mental disorders. While it seems prudent and self-evident that the period of incarceration provides an opportunity to either establish health insurance or to ensure its continuity, federal disability benefits including Social Security disability insurance along with Medicaid or Medicare coverage during incarceration are unfortunately discontinued (rather than suspended) in most states upon incarceration (10) and may require several months before reinstatement (10, 41, 42). Efforts to address this enabling resource either through the advent of affordable healthcare coverage with the proposed healthcare reform or through suspension rather than disenrollment of inmates from public entitlements, may contribute greatly to HIV outcomes, especially when integrated with effective treatment of substance use and psychiatric disorders.
Among homeless individuals, other important enabling factors are those involving the competing needs for survival. In accordance with Maslow’s Hierarchy of Needs, individuals have pressing needs for survival and sustenance, and they must address these basic needs (food, shelter, safety) before they can address secondary needs (i.e., healthcare engagement) (43). Struggles with food insecurity or finding adequate housing can often interfere with ability to maintain linkages to HIV care or proper medication adherence (4, 21, 44). Among homeless jail detainees, unstable or unknown housing status upon release and food insecurity decreased likelihood of having an HIV provider and taking ART, respectively. Food insecurity, in our homeless sample, was associated with suboptimal adherence to ART, similar to findings in sub-Saharan Africa (45–47), suggesting that there are incredible pockets of poverty and healthcare inequity even within resource rich countries. We noted, however, that having health insurance modified the effect of food insecurity, as food insecurity decreased the likelihood of having a HIV provider only among those without health insurance. Having health insurance may indicate an existing linkage to care and thus, access to other resources that may have attenuated access to food. Addressing the needs of housing among jail detainees at risk for homelessness upon release is essential to improving their adherence to HIV care and medications. Ensuring that there is no gap in health insurance coverage may also attenuate some of the effects of food insecurity on medication adherence.
Need factors relevant to this vulnerable population include the presence of active psychiatric illnesses. HIV-infected inmates are more likely to have psychiatric disorders compared to their uninfected counterparts, and inmates with mental illness often have a history of homelessness (48, 49). The high prevalence of severe depression or anxiety in our study is of concern because depression has been associated with decreased adherence (50, 51). Fortunately, depression is treatable using relatively safe and inexpensive medications with little known drug interactions with HIV therapeutics (52). Treatment of mental illness has been shown to improve HIV outcomes among depressed, HIV-infected homeless and drug-using individuals (51, 53). Receiving outpatient psychiatric treatment increased the likelihood of having an HIV provider, suggesting that treatment of psychiatric disorders facilitates access to HIV primary care services or alternatively, having HIV primary care is associated with screening and treatment for psychiatric disorders. Irrespective of the direction, there is a need to ensure access to coordinated healthcare services for this population.
Similarly, having stable housing improves mental health, which was confirmed by the Housing and Health study in which homeless or unstably-housed, HIV-infected individuals who received housing-assistance services had greater improvement in their mental health scores compared to those who received standard case management services (21). It remains unclear, however, whether addressing the housing needs using a “Housing First” model or addressing the psychiatric disorder would have a greater impact on health outcomes in this population. Either approach, however, would need to address evidence-based treatment for substance use disorders, particularly those with the triple diagnoses (homelessness, mental illness, and drug dependence), because there is often an intertwined and revolving cycle between homelessness and the criminal justice system in the context of active drug or alcohol use in the U.S. (48, 49, 54–56)
Overall, the prevalence of active drug use and increased severity was higher among the homeless than non-homeless, and although drug use was not associated with having an HIV provider, it was associated with decreased likelihood of taking ART and with suboptimal adherence. In the total U.S. jail population, over two thirds of inmates admit to regular substance use, and in this HIV-infected cohort, 79% reported using any drug within 30 days of incarceration (57). Among non-incarcerated PLWHA, ART adherence is decreased among active drug users compared to former drug users or non-users (58, 59). Interventions such as provision of directly administered antiretroviral therapy (DAART) to PLWHA with substance use disorders significantly improve adherence and virologic outcomes (60–64). Unfortunately, this is a resource-intensive strategy, and improvements are time-limited and regress to the mean after the intervention has ended (65). Medication-assisted treatment (MAT) for opioid dependence has been shown effective in decreasing substance use as well as decreasing HIV risk behavior and improving HIV treatment outcomes (11, 66–71). Treatment with MAT, particularly for longer time periods, is associated with improved HIV treatment outcomes (72, 73). Currently, inmates are rarely started or even continued on opioid agonist treatment (buprenorphine or methadone) when incarcerated although MAT started prior to or upon release from prison has proven feasible and effective in this high-risk population (11, 74). Cocaine use, prevalent among this study population and among jail detainees in general, negatively contributes to HIV treatment outcomes. MAT targeting cocaine use is currently not available and even the promise of an effective cocaine vaccine (75) may not be effective in persons with compromised immune systems. The high prevalence of drug use and its negative association with taking ART and on ART adherence highlight the importance of incorporating effective drug treatment strategies as part of effective interventions among this population.
Alcohol use disorders (AUDs) remain a major problem among incarcerated persons as 66% of U.S. inmates admit to regular alcohol use and 33% were under the influence of alcohol at the time of offense (57). Alcohol use disorders negatively impact HIV treatment outcomes (76). Among homeless HIV-infected jail detainees increasing severity of alcohol use decreases likelihood of having of having a HIV provider among the homeless, but not among their housed counterparts. In addition, alcohol use in the month prior to incarceration was associated with a lower prevalence of suboptimal adherence among the non-homeless and because of the small sample size, only a trend of suboptimal adherence and alcohol use among the homeless. This is consistent with previous studies that have found recent alcohol use also associated with poor adherence to ART (76–78). Paradoxically, recent alcohol use among non-homeless individuals was associated with an increased likelihood of having an HIV provider. Recent alcohol use may be a marker, however, for more moderate alcohol use and not with the more chaotic use and destabilizing lifestyles associated with those with alcohol dependence and abuse or even hazardous drinking (76). The differential effect of alcohol on healthcare utilization is likely secondary to the heterogeneous definitions used for describing alcohol use disorders in research studies (76). In this analysis the definition of alcohol use was any use in the last 30 days, and therefore this broad definition does not necessarily constitute an alcohol use disorder (76). The alcohol section of the ASI, however, does indicate severity of alcohol use, and there is overwhelming evidence that alcohol use is associated with worse virologic outcomes and poor adherence to ART (76–78). It is therefore crucial to consider the use of contemporary and effective MAT for AUDs, including use of extended release naltrexone, especially for those transitioning through the CJS (79).
There are several limitations to this analysis. This study is limited by its cross-sectional nature and relying on self-report for our health care utilization measures. In addition, there are several predisposing and need factors and enabling resources that were not measurable with the data available that may have independently contributed to outcomes. For example, personal health beliefs, the concurrent use of MAT to treat SUDs and the degree to which social support was available were not included in our analysis. Variation in pill burden and side effects of various ART regimens, known variables affecting adherence, were also not available to be included in our analysis. Though we limited the assessment period of medication adherence to seven days prior to incarceration to reduce recall bias (80), this period may reflect social instability for a number of reasons, including homelessness, drug use and/or unbridled mental illness. Irrespective of other concomitant contributions to the preincarceration instability, however, it nonetheless results in poor healthcare utilization and poor ART adherence that may complicate HIV treatment outcomes. Also, though self-report is a well-validated tool to assess a number of our dependent and independent variables, the timing between incarceration and the survey varied by site, potentially introducing recall bias. Notwithstanding these limitations, this serves as the largest study to date examining HIV treatment outcomes among those who enter through jail and provides a glimpse of the care (or lack thereof) that was afforded to these homeless and non-homeless individuals while in community settings. It provides considerable insight into the need to develop and implement evidence-based community and jail-release interventions for this particularly vulnerable and understudied population.
Conclusion
Among HIV-infected individuals, the interconnected web of homelessness and incarceration is often complicated by substance use and mental illness, all of which can impact engagement in HIV care. Despite the safety net provided by Ryan White coverage for medical care, having health insurance still remains an important component to optimal HIV treatment outcomes. In addition, addressing the fundamental needs of housing and food is an essential factor in ensuring adherence to care among homeless jail detainees. The Enhancing Linkages Initiative will allow us to explore the effectiveness of enhanced case management services in addressing these needs and the impact this has on HIV care.
Acknowledgments
Enhancing Linkages to HIV Primary Care Services Initiative is a HRSA-funded Special Project of National Significance. Funding for this research was also provided through career development grants from the National Institute on Drug Abuse (K23 DA019381, SAS; K24 DA017072, FLA; R01-DA027204, JD; R01DA028692-02S1, NEC), research grants from the National Institute on Alcohol Abuse and Alcoholism (R01 AA018944, SAS & FLA), and National Institute of Mental Health (R01-MH076068, JD), and an institutional research training grant from the NIMH (T32 MH020031, JPM.) The funding sources played no role in study design, data collection, data analysis, data interpretation, writing of the manuscript or the decision to submit the paper for publication.
Bibliography
- 1.Bureau of Justice Statistics. [Accessed November 22, 2010];Total Correctional Population. http://bjs.ojp.usdoj.gov/index.cfm?ty=tp&tid=11.
- 2.Sabol WJ, Minton TD. Bureau of Justice Statistics Bulletin. Washington, DC: Office of Justice Programs, U.S. Department of Justice; 2008. Jail Inmates at Midyear 2007. [Google Scholar]
- 3.Assessment of sexually transmitted diseases services in city and county jails--United States, 1997. MMWR Morb Mortal Wkly Rep. 1998;47(21):429–31. [PubMed] [Google Scholar]
- 4.Schwarcz SK, Hsu LC, Vittinghoff E, Vu A, Bamberger JD, Katz MH. Impact of housing on the survival of persons with AIDS. BMC Public Health. 2009;9:220. doi: 10.1186/1471-2458-9-220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.van Olphen J, Eliason MJ, Freudenberg N, Barnes M. Nowhere to go: how stigma limits the options of female drug users after release from jail. Subst Abuse Treat Prev Policy. 2009;4:10. doi: 10.1186/1747-597X-4-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Williams BA, McGuire J, Lindsay RG, Baillargeon J, Cenzer IS, Lee SJ, et al. Coming Home: Health Status and Homelessness Risk of Older Pre-release Prisoners. J Gen Intern Med. 2010;25(10):1038–44. doi: 10.1007/s11606-010-1416-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38(12):1754–60. doi: 10.1086/421392. [DOI] [PubMed] [Google Scholar]
- 8.Baillargeon J, Giordano TP, Harzke AJ, Spaulding AC, Wu ZH, Grady JJ, et al. Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS. 2010;24(6):389–94. doi: 10.1089/apc.2009.0303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79. doi: 10.1093/cid/cir446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Baillargeon J, Giordano TP, Rich JD, Wu ZH, Wells K, Pollock BH, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301(8):848–57. doi: 10.1001/jama.2009.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Springer SA, Chen S, Altice FL. Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health. 2010;87(4):592–602. doi: 10.1007/s11524-010-9438-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison--a high risk of death for former inmates. N Engl J Med. 2007;356(2):157–65. doi: 10.1056/NEJMsa064115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Springer SA, Altice FL. Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep. 2005;2(4):165–70. doi: 10.1007/s11904-005-0011-9. [DOI] [PubMed] [Google Scholar]
- 14.Morrissey JP, Cuddeback GS, Cuellar AE, Steadman HJ. The role of Medicaid enrollment and outpatient service use in jail recidivism among persons with severe mental illness. Psychiatr Serv. 2007;58(6):794–801. doi: 10.1176/ps.2007.58.6.794. [DOI] [PubMed] [Google Scholar]
- 15.Meyer JP, Chen NE, Springer SA. Challenges to effective HIV treatment in the criminal justice population. AIDS Research and Treatment. 2011 doi: 10.1155/2011/680617. In press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Courtenay-Quirk C, Pals SL, Kidder DP, Henny K, Emshoff JG. Factors associated with incarceration history among HIV-positive persons experiencing homelessness or imminent risk of homelessness. J Community Health. 2008;33(6):434–43. doi: 10.1007/s10900-008-9115-7. [DOI] [PubMed] [Google Scholar]
- 17.Kushel MB, Hahn JA, Evans JL, Bangsberg DR, Moss AR. Revolving doors: imprisonment among the homeless and marginally housed population. Am J Public Health. 2005;95(10):1747–52. doi: 10.2105/AJPH.2005.065094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kidder DP, Wolitski RJ, Pals SL, Campsmith ML. Housing status and HIV risk behaviors among homeless and housed persons with HIV. J Acquir Immune Defic Syndr. 2008;49(4):451–5. doi: 10.1097/qai.0b013e31818a652c. [DOI] [PubMed] [Google Scholar]
- 19.Cohen CI, Sokolovsky J, Crane M. Aging, homelessness, and the law. Int J Law Psychiatry. 2001;24(2–3):167–81. doi: 10.1016/s0160-2527(01)00067-x. [DOI] [PubMed] [Google Scholar]
- 20.Kidder DP, Wolitski RJ, Campsmith ML, Nakamura GV. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007;97(12):2238–45. doi: 10.2105/AJPH.2006.090209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wolitski RJ, Kidder DP, Pals SL, Royal S, Aidala A, Stall R, et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav. 2010;14(3):493–503. doi: 10.1007/s10461-009-9643-x. [DOI] [PubMed] [Google Scholar]
- 22.Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One. 2009;4(11):e7558. doi: 10.1371/journal.pone.0007558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Flanigan T, Zaller N, Beckwith CG, Bazerman LB, Rana A, Gardner A, et al. Testing for HIV, Sexually Transmitted Infections, and Viral Hepatitis in Jails: Still a Missed Opportunity for Public Health and HIV Prevention. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S78–S83. doi: 10.1097/QAI.0b013e3181fbc94f. [DOI] [PubMed] [Google Scholar]
- 24.Pai NP, Estes M, Moodie EE, Reingold AL, Tulsky JP. The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco county jail. PLoS One. 2009;4(9):e7115. doi: 10.1371/journal.pone.0007115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10. [PubMed] [Google Scholar]
- 26.Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302. [PMC free article] [PubMed] [Google Scholar]
- 27.Health Resources and Services Administration, HIV/AIDS Bureau. [Accessed March 4, 2011.2006];Outreach: Engaging people in HIV care, summary of a HRSA/HAB 2005 consultation on linking PLWH into care. Available at ftp://ftp.hrsa.gov/hab/HIVoutreach.pdf.
- 28.Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection. Clin Infect Dis. 2011;52(6):793–800. doi: 10.1093/cid/ciq243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Spaulding AC, Jacob Arriola KR, Ramos KL, Hammett T, Kennedy S, Norton G, et al. Enhancing Linkages to HIV Primary Care in Jail Settings. Journal of Correctional Health Care. 2007;13(2):93–128. [Google Scholar]
- 30.Draine J, Ahuja D, Altice FL, Arriola KJ, Avery AK, Beckwith CG, et al. Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011;23(3):366–77. doi: 10.1080/09540121.2010.507738. [DOI] [PubMed] [Google Scholar]
- 31.Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescent: Department of Health and Human Services. 2009 Dec 1;:1–161. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
- 32.Bangsberg DR. Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: The past, the present, and the future. AIDS Behav. 2006;10(3):249–51. doi: 10.1007/s10461-006-9121-7. [DOI] [PubMed] [Google Scholar]
- 33.Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. doi: 10.7326/0003-4819-133-1-200007040-00004. [DOI] [PubMed] [Google Scholar]
- 34.McLellan AT, Cacciola JC, Alterman AI, Rikoon SH, Carise D. The Addiction Severity Index at 25: origins, contributions and transitions. Am J Addict. 2006;15(2):113–24. doi: 10.1080/10550490500528316. [DOI] [PubMed] [Google Scholar]
- 35.McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26–33. doi: 10.1097/00005053-198001000-00006. [DOI] [PubMed] [Google Scholar]
- 36.McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199–213. doi: 10.1016/0740-5472(92)90062-s. [DOI] [PubMed] [Google Scholar]
- 37.Calsyn DA, Saxon AJ, Bush KR, Howell DN, Baer JS, Sloan KL, et al. The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. Drug Alcohol Depend. 2004;76(2):165–71. doi: 10.1016/j.drugalcdep.2004.04.018. [DOI] [PubMed] [Google Scholar]
- 38.Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):59–79. doi: 10.1016/S0140-6736(10)60829-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Institute of Medicine. HIV Screening and Access to Care: Exploring the Impact of Policies on the Access to and Provision of HIV Care. Washington, DC: The National Academies Press; 2011. [PubMed] [Google Scholar]
- 40.U.S. Department of Health and Human Services Health Resources and Services Administration. The HIV/AIDS Program. 2010 Dec 9;2010 Available from: http://hab.hrsa.gov/aboutus.htm. [Google Scholar]
- 41.Wakeman SE, McKinney ME, Rich JD. Filling the gap: the importance of Medicaid continuity for former inmates. J Gen Intern Med. 2009;24(7):860–2. doi: 10.1007/s11606-009-0977-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Wilson AB. It Takes ID to Get ID: The New Identity Politics in Services. Soc Serv Rev. 2009;83(1):111–32. [Google Scholar]
- 43.Maslow AH. Toward a Psychology of Being. 3. New York, NY: John Wiley and Sons, Inc; 1998. [Google Scholar]
- 44.Gelberg L, Gallagher TC, Andersen RM, Koegel P. Competing priorities as a barrier to medical care among homeless adults in Los Angeles. Am J Public Health. 1997;87(2):217–20. doi: 10.2105/ajph.87.2.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Anema A, Vogenthaler N, Frongillo EA, Kadiyala S, Weiser SD. Food insecurity and HIV/AIDS: current knowledge, gaps, and research priorities. Curr HIV/AIDS Rep. 2009;6(4):224–31. doi: 10.1007/s11904-009-0030-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Kagee A, Remien RH, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: Challenges and potential ways forward. Glob Public Health. 2010:1–15. doi: 10.1080/17441691003796387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One. 2010;5(4):e10340. doi: 10.1371/journal.pone.0010340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Baillargeon JG, Paar DP, Wu H, Giordano TP, Murray O, Raimer BG, et al. Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting. AIDS Care. 2008;20(1):124–9. doi: 10.1080/09540120701426532. [DOI] [PubMed] [Google Scholar]
- 49.Michaels D, Zoloth SR, Alcabes P, Braslow CA, Safyer S. Homelessness and indicators of mental illness among inmates in New York City’s correctional system. Hosp Community Psychiatry. 1992;43(2):150–5. doi: 10.1176/ps.43.2.150. [DOI] [PubMed] [Google Scholar]
- 50.Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89. doi: 10.2165/00003495-200666060-00004. [DOI] [PubMed] [Google Scholar]
- 51.Springer SA, Chen S, Altice F. Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Care. 2009;21(8):976–83. doi: 10.1080/09540120802657555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Saber-Tehrani AS, Bruce RD, Altice FL. Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence. Am J Drug Alcohol Abuse. 2011;37(1):1–11. doi: 10.3109/00952990.2010.540279. [DOI] [PubMed] [Google Scholar]
- 53.Tsai AC, Weiser SD, Petersen ML, Ragland K, Kushel MB, Bangsberg DR. A Marginal Structural Model to Estimate the Causal Effect of Antidepressant Medication Treatment on Viral Suppression Among Homeless and Marginally Housed Persons With HIV. Arch Gen Psychiatry. 2010;67(12):1282–90. doi: 10.1001/archgenpsychiatry.2010.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Baillargeon J, Binswanger IA, Penn JV, Williams BA, Murray OJ. Psychiatric disorders and repeat incarcerations: the revolving prison door. Am J Psychiatry. 2009;166(1):103–9. doi: 10.1176/appi.ajp.2008.08030416. [DOI] [PubMed] [Google Scholar]
- 55.Hopper K, Jost J, Hay T, Welber S, Haugland G. Homelessness, severe mental illness, and the institutional circuit. Psychiatr Serv. 1997;48(5):659–65. doi: 10.1176/ps.48.5.659. [DOI] [PubMed] [Google Scholar]
- 56.James DJGL. Bureau of Justice Statistics Special Report, NCJ 213600. Washington, DC: US Department of Justice; Sep, 2006. [Accessed on December 17, 2010]. Mental Health Problems of Prison and Jail Inmates. http://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&iid=789. [Google Scholar]
- 57.James DJ. Bureau of Justice Statistics Special Report: Profile of Jail Inmates. Washington, DC: U.S. Department of Justice Office of Justice Programs; 2002. [Accessed December 11, 2010–2004]. http://bjs.ojp.usdoj.gov/content/pub/pdf/pji02.pdf. [Google Scholar]
- 58.Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17(5):377–81. doi: 10.1046/j.1525-1497.2002.10644.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2001;27(3):251–9. doi: 10.1097/00126334-200107010-00006. [DOI] [PubMed] [Google Scholar]
- 60.Altice FL, Mezger JA, Hodges J, Bruce RD, Marinovich A, Walton M, et al. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clin Infect Dis. 2004;38 (Suppl 5):S376–87. doi: 10.1086/421400. [DOI] [PubMed] [Google Scholar]
- 61.Babudieri S, Aceti A, D’Offizi GP, Carbonara S, Starnini G. Directly observed therapy to treat HIV infection in prisoners. JAMA. 2000;284(2):179–80. doi: 10.1001/jama.284.2.179. [DOI] [PubMed] [Google Scholar]
- 62.Lucas GM, Weidle PJ, Hader S, Moore RD. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clin Infect Dis. 2004;38 (Suppl 5):S409–13. doi: 10.1086/421405. [DOI] [PubMed] [Google Scholar]
- 63.Altice FL, Maru DS, Bruce RD, Springer SA, Friedland GH. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis. 2007;45(6):770–8. doi: 10.1086/521166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Altice FL, Tehrani AS, Qiu J, Herme M, Springer SA. Directly Administered Antriretroviral Therapy (DAART) is Superior to Self-Administered Therapy (SAT) Among Released HIV+. Prisoners: Results from a Randomized Controlled Trial 18th Conference on Retroviruses and Opportunistic Infections; February 27-March 2, 2011; Boston, MA. 2011. p. Abstract K-131. [Google Scholar]
- 65.Maru DS, Bruce RD, Walton M, Springer SA, Altice FL. Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial. J Acquir Immune Defic Syndr. 2009;50(2):176–81. doi: 10.1097/QAI.0b013e3181938e7e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Gowing LR, Farrell M, Bornemann R, Sullivan LE, Ali RL. Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection. J Gen Intern Med. 2006;21(2):193–5. doi: 10.1111/j.1525-1497.2005.00287.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Metzger DS, Woody GE, McLellan AT, O’Brien CP, Druley P, Navaline H, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993;6(9):1049–56. [PubMed] [Google Scholar]
- 68.Metzger DS, Zhang Y. Drug treatment as HIV prevention: expanding treatment options. Curr HIV/AIDS Rep. 2010;7(4):220–5. doi: 10.1007/s11904-010-0059-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Wong KH, Lee SS, Lim WL, Low HK. Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users. J Subst Abuse Treat. 2003;24(3):233–9. doi: 10.1016/s0740-5472(03)00029-1. [DOI] [PubMed] [Google Scholar]
- 70.Sullivan LE, Fiellin DA. Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence. Clin Infect Dis. 2005;41(6):891–6. doi: 10.1086/432888. [DOI] [PubMed] [Google Scholar]
- 71.Krupitsky EM, Zvartau EE, Masalov DV, Tsoy MV, Burakov AM, Egorova VY, et al. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Subst Abuse Treat. 2006;31(4):319–28. doi: 10.1016/j.jsat.2006.05.005. [DOI] [PubMed] [Google Scholar]
- 72.Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr. 2011;56 (Suppl 1):S22–32. doi: 10.1097/QAI.0b013e318209751e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, et al. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clin Infect Dis. 2009;49(9):1433–40. doi: 10.1086/630209. [DOI] [PubMed] [Google Scholar]
- 74.Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT, O’Grady KE. A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat. 2009;37(3):277–85. doi: 10.1016/j.jsat.2009.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T, et al. Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch Gen Psychiatry. 2009;66(10):1116–23. doi: 10.1001/archgenpsychiatry.2009.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–93. doi: 10.1016/j.drugalcdep.2010.06.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Mellins CA, Havens JF, McDonnell C, Lichtenstein C, Uldall K, Chesney M, et al. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care. 2009;21(2):168–77. doi: 10.1080/09540120802001705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572–7. doi: 10.1097/01.alc.0000122103.74491.78. [DOI] [PubMed] [Google Scholar]
- 79.Springer SA, Azar MM, Altice FL. HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse. 2011;37(1):12–21. doi: 10.3109/00952990.2010.540280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45. doi: 10.1007/s10461-006-9078-6. [DOI] [PMC free article] [PubMed] [Google Scholar]